TGEN - Targeted Genetics Corporation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : TGEN - Targeted Genetics Corporation

TGEN 9.980

+4.1%

Oct 31 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mike McFarland who wrote (551)	10/27/2008 6:19:10 PM
From: Mike McFarland	Read Replies (1) of 557

Targeted Genetics Announces Presentation of Data From Completed Phase 1/2 tgAAC94 Trial at American College of Rheumatology Study Achieves Primary Endpoint of Safety and Tolerability; Improvement in Patient-Reported Outcome Measures Observed ir.targen.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next